| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $102.5M | +65.2% |
| R&D Expense | $166.4M | -34.0% |
| SG&A Expense | $41.0M | -15.3% |
| Operating Income | -$158.4M | +33.6% |
| Pre-tax Income | -$191.2M | +15.1% |
| Income Tax | -$93K | -103.9% |
| Net Income | -$191.1M | +16.0% |
| EPS (Basic) | -$22.49 | -659.8% |
| EPS (Diluted) | -$22.49 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $58.1M | -69.5% |
| Short-term Investments | $83.3M | -34.2% |
| Accounts Receivable | $4.0M | -53.8% |
| Current Assets | $150.9M | -56.0% |
| Total Assets | $173.8M | -55.1% |
| Current Liabilities | $75.1M | -43.0% |
| Total Liabilities | $306.3M | -10.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$177.2M | +7.5% |
| Investing Cash Flow | $45.0M | -79.4% |
| Financing Cash Flow | $44K | -100.0% |
| -659.8% |
| Stockholders' Equity |
| -$132.5M |
| -397.0% |